Am J Transplant, Volume 16, Suppl 3 Archives - Page 164 of 180 - ATC Abstracts

2016 American Transplant Congress
Pregnancy in the Renal Transplant Recipient: Pregnancy Viability and Effects on Graft Function.
A. Lima, M. Cristelli, C. Teixeira, I. Pietrobom, G. Basso, L. Viana, M. de Paula, C. C[acirc]ndido, H. Tedesco-Silva, J. Pestana.
Nephrology, Hospital do Rim, São Paulo, Brazil.
Background: Fertility in women is recovered few months after kidney transplantation. However, pregnancy viability and maternal complications remain uncertain. Methods: We studied data of patients…
2016 American Transplant Congress
Evaluation of Patient-Reported Nonadherence with Tacrolimus Level Variability in Renal Transplant Recipients.
N. Parrish,¹ T. Kaiser,² A. McCann,¹ J. Aladimi,² J. Harris,³ A. Govil,² B. Abu Jawdeh,² G. Mogilishetty,² R. Alloway,² E. Woodle.²
¹Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH; ²Medicine, University of Cincinnati, Cincinnati, OH; ³Transplant, University of Cincinnati Medical Center, Cincinnati, OH.
Medication nonadherence (NA) continues to be a major cause of graft loss post-transplant. Several methods for prospective adherence monitoring have been described including patient interview…
2016 American Transplant Congress
An In-Situ Treatment of Donor Skin Induces MARCH1 and Decreases MHC II Expression on Donor Dendritic Cells, Promoting Skin Allograft Acceptance.
T. Borges,^1,2 F. Machado,¹ C. Bonorino,¹ L. Riella.²
¹School of Biosciences and Biomedical Research Institute, PUCRS, Porto Alegre, RS, Brazil; ²Schuster Family Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Background: Skin transplants are the most immunogenic of all transplants and donor DCs play a crucial role in activating effector alloreactive T cells and initiating…
2016 American Transplant Congress
Natural Killer CD16/FcR Profiles May Associate with Enhanced Humoral Responsiveness in Heart Transplant Recipients with Cardiac Allograft Vasculopathy.
P. Paul,^1,2 C. Picard,^3,4 E. Sampol,⁵ L. Lyonnet,¹ J. Di Cristofaro,^3,4 G. Lano,^6, B. Dussol,^6, F. Collart,⁷ F. Sabatier,^1,2 F. Dignat George,^1,2 A. Mouly Bandini.⁷
¹Hematology, Assistance Publique-Hopitaux Marseille (AP-HM), Marseille, France; ²UMR-1076, Aix Marseille Université (AMU), INSERM, Marseille, France; ³Établissement Français du Sang, Marseille, France; ⁴UMR7268, AMU, CNRS, Marseille, France; ⁵Pharmacokinetics, AP-HM, Marseille, France; ⁶Center for Clinical Investigation, AP-HM, Marseille, France; ⁷Cardiac Surgery, AP-HM, Marseille, France.
Natural Killer cells (NK) are immune effectors of antibody-dependent cellular cytotoxicity (ADCC). Their role in mediating adverse effects of Donor-specific anti-HLA antibodies (DSA) towards cardiac…
2016 American Transplant Congress
Systematic Pathological Component Scores for Skin-Containing Vascularized Composite Allografts.
I. Rosales,¹ M. DeFazio,² R. Foreman,¹ D. Sachs,² C. Cetrulo,² D. Leonard,^2,3 R. Colvin.¹
¹Pathology, Massachusetts General Hospital, Boston; ²Transplantation Biology Research Center, Plastic and Reconstructive Surgery, Massachusetts General Hospital, Boston; ³Plastic and Reconstructive Surgery, Countess of Chester Hospital, Chester, United Kingdom.
Successful application of skin-containing vascularized composite allografts (VCA) depends on accurate assessment of the graft status typically based on skin biopsies. A working classification (Banff…
2016 American Transplant Congress
Identification of MicroRNAs in EBV⁺ B Cell Lymphomas and Secreted Exosomes.
V. Kaul, A. Harris-Arnold, C. Esquivel, O. Martinez, S. Krams.
Division of Abdominal Transplantation, Dept. of Surgery, Stanford University, Stanford.
Introduction Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation commonly associated with Epstein Barr virus (EBV) infection. EBV viral loads are…
2016 American Transplant Congress
Kidney Waitlist Management with Lean Six Sigma.
V. Arelin,¹ J. Schaefer,³ H. Haller,¹ I. Ackermann,² H. Schrem.²
¹Nephrology and Hypertension, Medical School Hanover, Hannover, Germany; ²Transplant and Viceral Surgery, Medical School Hanover, Hannover, Germany; ³Center for Information Technology, Medical School Hanover, Hannover, Germany.
BackgroundLean thinking is a bundle of concepts, methods and tools for organizing human activities in organizations. It attempts to eliminate the underlying unnecessary waste in…
2016 American Transplant Congress
Early Proteomic Predictors of Late Chronic Kidney Disease in Liver Transplant Recipients.
J. Levitsky,¹ S. Asrani,² L. Zhao,¹ M. Abecassis,¹ L. Jennings,² G. Klintmalm.²
¹Northwestern, Chicago; ²Baylor, Dallas.
Background: A high proportion of patients develop chronic kidney disease (CKD) after liver transplantation (LT). However, the ability to better select patients for nephroprotective interventions…
2016 American Transplant Congress
The Effect of DRI and KDPI on Outcomes of High MELD Patients Undergoing Simultaneous Liver Kidney Transplant.
E. Chan,¹ M. Hertl,¹ J. Perkins.²
¹General Surgery, Rush University Medical Center, Chicago, IL; ²Surgery, University of Washington, Seattle, WA.
Background: Patients with a high Model for End Stage Liver Disease (MELD) score have an increased risk for dying without transplant. Renal function worsens secondary…
2016 American Transplant Congress
Predictors of Patient Uncertainty Regarding Treatment Options Among End Stage Renal Disease Patients Evaluated for Kidney Transplantation.
L. McPherson,¹ M. Basu,¹ S. Pastan,¹ S. Mohan,² M. Wolf,³ J. Gander,¹ R. Patzer.¹
¹Emory University, Atlanta, GA; ²Columbia University, New York City, NY; ³Northwestern University, Chicago, IL.
Background: Although kidney transplantation (KTx) provides a significant survival benefit over long-term dialysis, many end stage renal disease (ESRD) patients are uncertain or conflicted about…